.
Resmed Inc (ASX:RMD) has announced a 19% increase in revenue to US$1.1billion for the year ended 30 June 2010.
Income from operations grew 26% to US$240.4 million with net income up 30% to US$190.1 million compared to a year ago.
Earnings per share for the 2009-10 financial year increased 29% to US$2.45.
The respiratory device manufacturer also announced record revenue and income for the June quarter of US$291.6 million.
President and CEO Kieran Gallahue says the fourth quarter of fiscal 2010 showed strong growth year-on-year in the Americas and international markets, surpassing the billion dollar mark in annual sales.
Resmed reported a $180.5 million profit for the year to 30 June 2009.
{"streaming_server":"rtmp:\/\/s2svek4dh1hfyu.cloudfront.net\/cfx\...
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
